English
  • Ruxolitinib

    Ruxolitinib

    Izina rya API Kwerekana Udushya Itariki yo kurangiriraho ipatanti (Amerika)
    Ruxolitinib Myelofibrosis Novartis Nyakanga 6, 2024
    ipererezaburambuye
  • Relugolix

    Relugolix

    Izina rya API Kwerekana Udushya Itariki yo kurangiriraho ipatanti (Amerika)
    Relugolix Kanseri ya prostate Takeda na ASKA Ku ya 24 Mutarama 2024
    ipererezaburambuye
  • Rimegepant

    Rimegepant

    Izina rya API Kwerekana Udushya Itariki yo kurangiriraho ipatanti (Amerika)
    Rimegepant Umutwe wa Migraine Biohaven Ku ya 22 Gashyantare 2031

     

    ipererezaburambuye
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
    Ribociclib CAS: 737789-87-6 Antineoplastique Mu nzu      
    ipererezaburambuye
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Izina rya API Kwerekana Udushya Itariki yo kurangiriraho ipatanti (Amerika)
    Ribociclib 1374639-75-4 HR-nziza, HER2-mbi Andvance ormetastaticbreast Kanseri Novartis
    Imiti    		 Jun.27, 2028
    ipererezaburambuye
  • Rivaroxaban

    Rivaroxaban

    Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
    Rivaroxaban Anticoagulant Mu nzu TDP    
    ipererezaburambuye
  • Rosuvastatin Calcium

    Kalisiyumu ya Rosuvastatin

    Izina rya API Kwerekana Ibisobanuro DMF yo muri Amerika EU DMF CEP
    Kalisiyumu ya Rosuvastatin Hypercholesterolemia Mu nzu / CEP 20705 √ CEP2015-240
    ipererezaburambuye